Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
Pamela Roberto, PhD
Advertisement
Articles by Pamela Roberto, PhD
Advertisement
Latest Updated Articles
- Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment
Published: May 7th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
4
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
5
